ELABELAVEGFR2.

Jia-Yu Peng1, Xiao Fu2, Xue-Yang Luo2

  • 1Institute for Developmental and Regenerative Cardiovascular Medicine, Xin Hua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Department of Pediatric Cardiology, Xin Hua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Department of Child Healthcare, The International Peace Maternity & Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

概括

内皮细胞ELABELA (ELA) 通过增加VEGFR2.2,通过增加缺血后的血管生长. 在糖尿病足患者中较低的ELA水平表明ELA是外周动脉疾病的治疗标.